Cytokine-Mediated STAT3 Transcription Supports ATGL/CGI-58-Dependent Adipocyte Lipolysis in Cancer Cachexia
Open Access
- 15 June 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 12, 841758
Abstract
Adipose tissue inflammation is observed in multiple metabolically-altered states including cancer-associated cachexia and obesity. Although cachexia is a syndrome of adipose loss and obesity is a disease of adipose excess, both pathologies demonstrate increases in circulating levels of IL-6 family cytokines, β-adrenergic signaling, and adipocyte lipolysis. While β-adrenergic-stimulated adipocyte lipolysis is well described, there is limited mechanistic insight into how cancer cachexia-associated inflammatory cytokines contribute to adipocyte lipolysis under pathologic conditions. Here, we set out to compare adipocyte lipolysis signaling by cancer cachexia-associated IL-6 family cytokines (IL-6 and LIF) to that of the β-adrenergic agonist isoproterenol. Unlike isoproterenol, the IL-6 family of cytokines required JAK/STAT3-dependent transcriptional changes to induce adipocyte lipolysis. Furthermore, cachexia-associated cytokines that used STAT3 to induce lipolysis were primarily dependent on the lipase ATGL and its cofactor CGI-58 rather than lipases HSL and MAGL. Finally, administration of JAK but not β-adrenergic inhibitors suppressed adipose STAT3 phosphorylation and associated adipose wasting in a murine model of cancer cachexia characterized by increased systemic IL-6 family cytokine levels. Combined, our results demonstrate how the IL-6 family of cytokines diverge from β-adrenergic signals by employing JAK/STAT3-driven transcriptional changes to promote adipocyte ATGL/CGI-58-dependent lipolysis contributing to adipose wasting in cancer cachexia.Keywords
Funding Information
- Burroughs Wellcome Fund (1019692)
- American Cancer Society (133889-RSG-19-195-01-TBE)
- AGA Research Foundation (R2019AGARSA3)
- Cancer Prevention and Research Institute of Texas (RP200170)
- National Institutes of Health (P30CA142543, 5T32GM007062-44, 5P01-HL20948)
- National Institute of Diabetes and Digestive and Kidney Diseases (1RO1DK128166-01A1)
This publication has 35 references indexed in Scilit:
- ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1Nature Medicine, 2011
- Definition and classification of cancer cachexia: an international consensusThe Lancet Oncology, 2011
- Role of β1‐adrenoceptor in increased lipolysis in cancer cachexiaCancer Science, 2010
- Mechanism of Increased Lipolysis in Cancer CachexiaCancer Research, 2007
- Lipase-selective Functional Domains of Perilipin A Differentially Regulate Constitutive and Protein Kinase A-stimulated LipolysisJournal of Biological Chemistry, 2003
- The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome—an analysis by structural equation modellingInternational Journal of Obesity, 2002
- Translocation of Hormone-sensitive Lipase and Perilipin upon Lipolytic Stimulation of Rat AdipocytesJournal of Biological Chemistry, 2000
- Identification of Novel Phosphorylation Sites in Hormone-sensitive Lipase That Are Phosphorylated in Response to Isoproterenol and Govern Activation Properties in VitroJournal of Biological Chemistry, 1998
- IL-6-Induced Homodimerization of gp130 and Associated Activation of a Tyrosine KinaseScience, 1993
- The IL-6 Signal Transducer, gp130: an Pncostatin M Receptor and Affinity Converter for the LIF ReceptorScience, 1992